Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2

Advances in molecular biology have resulted in novel therapy for neurofibromatosis 2-related (NF2) tumours, highlighting the need for robust outcome measures. The disease-focused NF2 impact on quality of life (NFTI-QOL) patient questionnaire was assessed as an outcome measure for treatment in a mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferner, Rosalie E., Shaw, Adam, Evans, D. Gareth, McAleer, Dympna, Halliday, Dorothy, Parry, Allyson, Raymond, F. Lucy, Durie-Gair, Juliette, Hanemann, C. Oliver, Hornigold, Rachel, Axon, Patrick, Golding, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008785/
https://www.ncbi.nlm.nih.gov/pubmed/24619350
http://dx.doi.org/10.1007/s00415-014-7303-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008785/
https://www.ncbi.nlm.nih.gov/pubmed/24619350
http://dx.doi.org/10.1007/s00415-014-7303-1

Ejemplares similares